IP Library Granted Patent US 10,364,270
Granted Patent B2
US 10,364,270 · App. 15/722,522 · Granted Jul 30, 2019

Eye-care peptide, its composition and method of using the same

Inventors: Min-Chuan Huang (Taipei, TW); Syue-Ting Chen (Taipei, TW); Yu-Chun Liu (Taoyuan, TW)
Assignee: PRO SUNFUN BIOTECH RESEARCH AND DEVELOPMMENT CO., LTD.
C07K7/06A61P27/02A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,364,270
App. No.
15/722,522
Granted
Jul 30, 2019
Kind
B2
Abstract

Disclosed is related to a synthetic peptide consisting of an amino acid sequence of ArgAsnProLeuGluGluThr (SEQ ID NO: 1). Also provided are a pharmaceutical composition benefic to eye care or eye health comprising the peptide, and a method for wound healing using the peptide.

Claims (8)

1. A pharmaceutical composition, comprising

a peptide consisting of the amino acid sequence set forth in SEQ ID NO: 1 in an amount effective to enhance the migration of fibroblast cells, and a pharmaceutically acceptable carrier, wherein said pharmaceutical composition is formulated in a systemic or topical form.

2. The pharmaceutical composition of claim 1 , which is formulated in a topical form.

3. The pharmaceutical composition of claim 1 , which is in a form of eye drop.

4. An eye-care method for treating eye damage, which comprises

administering to a subject in need thereof the pharmaceutical composition of claim 1 in an amount effective to enhance the migration of corneal epithelial cells in the subject.

5. The method of claim 4 , wherein the pharmaceutical composition is topically administered to the subject.

6. The method of claim 4 , wherein the pharmaceutical composition is formulated in a form of eye drop.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2017
From: HUANG, MIN-CHUAN; CHEN, SYUE-TING; LIU, YU-CHUN
To: PRO SUNFUN BIOTECH RESEARCH AND DEVELOPMENT CO., LTD.
Reel/Frame 044966/0721 →
Continuity (1)
Related Publication 20190100555A1 · Apr 4, 2019